Aberrant FBXW7 is involved in the development of cancer drug resistance (apoptosis resistance, EMT, stem cell characterization, shaping of the tumor microenvironment, autophagy and immune evasion) by causing an imbalance in oncoproteins. The gene discussed is FBXW7; the disease is neoplasm.